C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/02 (2006.01) C07F 9/6571 (2006.01)
Patent
CA 2556868
The present invention refers to a method for identification of a chemical compound which modulates the activity of mammalian GPI-PLC wherein a] a mammalian cell is incubated with glimepiride; b] hcDlGs of the cells of a] are prepared; c] the hcDlGs from b] are incubated with a chemical compound; d] the activity of the GPI-PLC from the hcDlGs of c] is determined.
L'invention concerne un procédé d'identification d'un composé chimique qui module l'activité d'une GPI-PLC mammifère. Ce procédé comprend a] l'incubation d'une cellule mammifère avec glimépiride, b] la préparation de hcDIG des cellules de a], c] l'incubation des hcDIG de b] avec un composé chimique et d] la détermination de l'activité de la GPI-PLC à partir des hcDIG de c].
Frick Wendelin
Mueller Guenter
Schneider Rudolf
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Glimepiride- and insulin-induced... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glimepiride- and insulin-induced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glimepiride- and insulin-induced... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1408836